Subscribe
dna-istock-518143098-ralwel-
Ralwel / iStockphoto.com
26 April 2017Americas

CRISPR webinar: HGF discusses IP landscape

LSIPR and law firm HGF held a webinar yesterday focusing on CRISPR and how to navigate the IP landscape.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
LSIPR webinar: BSKB dissects antibody patents
1 February 2018   When it comes to patenting antibodies, “written description seems to be the big issue these days”, according to Gerald Murphy, IP partner at law firm Birch Stewart Kolasch Birch.
Europe
LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF
22 March 2018   Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Europe
LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF
22 March 2018   Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure.
Americas
LSIPR webinar: BSKB dissects antibody patents
1 February 2018   When it comes to patenting antibodies, “written description seems to be the big issue these days”, according to Gerald Murphy, IP partner at law firm Birch Stewart Kolasch Birch.

More on this story

Europe
LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF
22 March 2018   Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure.
Americas
LSIPR webinar: BSKB dissects antibody patents
1 February 2018   When it comes to patenting antibodies, “written description seems to be the big issue these days”, according to Gerald Murphy, IP partner at law firm Birch Stewart Kolasch Birch.

More features

Gilead awarded $30m over counterfeit HIV drug scheme
EPO invalidates human milk patent after Nestle opposition
Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic